Reports from the US say that the US Food and Drug Administration Anesthetic and Analgesic Drug Products Advisory Committee has voted 14 to nil against QRX’s Moxduo dual opioid.
QRX Price at posting:
70.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
